期刊文献+

T2DM合并NAFLD患者肌电图的临床特点

The clinical characteristics of EMG in T2DM patients with NAFLD
下载PDF
导出
摘要 目的探讨2型糖尿病(T2DM)患者中合并非酒精性脂肪肝(NAFLD)肌电图的临床特点。方法选取T2DM患者449例,按是否合并N AFLD分为单纯T2DM组(T2DM组)114例,合并NAFLD组(T2DM-NAFLD组)335例。比较两组患者的各项参数,并行相关性分析结果与T2DM组比较,T2DM-NAFLD组体重、腰围、臀围、腰臀比(WHR)、收缩压(SBP)、舒张压(DBP)、血清尿酸(SUA)、谷丙转氨酶(ALT)、谷草转氨酶(AST)、总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白(LDL)、空腹C肽(FCP)、餐后2小时C肽(2 hCP)、胰岛素抵抗指数(HOMA-IR)值升高明显(P<0.05)。Pearson相关分析显示,肌电图异常与ALT、FCP、2 hCP、HOMA-IR呈负相关,与年龄、糖化血红蛋白(HbAlc)呈正相关。进一步行Logistic分析,年龄、HbAlc为肌电图异常的独立危险因素,结论合并NAFLD的T2DM患者肌电图异常的患病率较低,机制不明。年龄、HbA1c为肌电图异常的独立危险因素。 Objective To explore the clinical features of electromyography in patients with non—alcoholic fatty liver(NAFLD)newly diagnosed with type 2 diabetes(T2DM).Methods A total of 449 newly diagnosed T2DM patients were selected.They were divided into 114 cases in the simple T2DM group(T2DM group)and 335 cases in the combined NAFLD group(T2DM—NAFLD group)according to whether NAFLD was combined.The parameters of the two groups of patients was compared,and the correlation was analyzed.Results Compared with the T2DM group,the T2DM—NAFLD 0 group's weight,waist circumference,hip circumference,WHR,SBP,DBP,SUA,AST,ALT,TC,TG,LDL,FCP,2 hCP,HOMA-IK values increased(P<0.05).Pearson correlation analysis showed that abnormal EMG was negatively correlated with ALT,FCP,2 hCP,HOMA—IR,and positively correlated with age and HbAlc.Further Logistics analysis showed that age and HbAlc were independent risk factors for abnormal EMG.Conclusion The prevalence of abnormal EMG in newly diagnosed T2DM patients with NAFLD is low,and the mechanism is unknown.Age and HbAlc are independent risk factors for abnormal EMG.
作者 张洁 胡江 蒋晓红 华飞 Zhang Jie
出处 《浙江临床医学》 2021年第2期187-189,共3页 Zhejiang Clinical Medical Journal
基金 江苏省常州市科技局项目(CJ20140061)。
关键词 2型糖尿病 非酒精性脂肪性肝病 肌电图 Type 2 diabetes Nonalcoholic fatty liver disease Electromyography
  • 相关文献

参考文献4

二级参考文献24

  • 1Carmen Fierbinteanu-Braticevici,Ion Dina,Ana Petrisor,Laura Tribus,Lucian Negreanu,Catalin Carstoiu.Noninvasive investigations for non alcoholic fatty liver disease and liver fi brosis[J].World Journal of Gastroenterology,2010,16(38):4784-4791. 被引量:21
  • 2Minoru Itou,Takumi Kawaguchi,Eitaro Taniguchi,Michio Sata.Dipeptidyl peptidase-4: A key player in chronic liver disease[J].World Journal of Gastroenterology,2013,19(15):2298-2306. 被引量:25
  • 3吴学苏.糖尿病与脂肪肝[J].糖尿病之友,2007(8):50-51. 被引量:3
  • 4周健,贾伟平,包玉倩,马晓静,陆蔚,喻明,潘洁敏,胡承,项坤三.2型糖尿病患者脂肪肝患病率调查及危险因素分析[J].中华医学杂志,2007,87(32):2249-2252. 被引量:31
  • 5Elisabetta Bugianesi MD,Ester Vanni MD,Giulio Marchesini MD.NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes[J].Current Diabetes Reports.2007(3)
  • 6Lu H,Zeng L,Liang B,et al.High prevalence of coronary heart diseasein type 2 diabetic patients with non-alcoholic fatty liver disease[].Arctic Medical Research.2009
  • 7Farrell GC,Larter CZ.Nonalcoholic fatty liver disease: from steatosis to cirrhosis[].Hepatology.2006
  • 8Tushuizen ME,Bunck MC,Pouwels PJ,et al.Incretin mimetics as a novel therapeutic option for hepatic steatosis〔J〕[].Liver International.2006
  • 9Ding X,Saxena NK,Lin S,Gupta NA,Anania FA.Exendin-4 a glucagon-like protein-1 (GLP-1) receptor agonist,reverses hepatic steatosis in ob/ob mice[].Hepatology.2006
  • 10R Meshkani,K Adeli.Hepatic insulin resistance, metabolic syndrome and cardiovascular disease[].Clinical Biochemistry.2009

共引文献257

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部